Browse: Companies | People | Financial Organizations
Home > Financial Organizations > Aravis Ventures

General Information

Websitearavis.ch
Phone+41 43 499 2000
Email
Employees
Descriptionventure company

Funds

Offices

Zuerich, CHE
Lehfrauenweg 10
Zuerich, CH-8053, CHE

People

Tags

Aravis Ventures

Aravis Ventures is a financial organisation which targets its investments in the fields of life sciences and renewable energy. Their investments are focused in Europe, Asia and North America.

Milestones

Investments

Company Date Round Size Participants
Evolva 10/09Series B$28M4
NovImmune 5/09Series D$54.8M7
Ambrx 4/09Series D$10M7
Synosia Therapeutics 1/09Series B$29M7
S*Bio 10/08Unattributed$26M6

Videos

Sources

  1. Evolva hauls in $28M to grease Arpida merger (fiercebiotech.com) [edit]
  2. NovImmune, SA: Series C $54.8M (onbiovc.com) [edit]
  3. Ambrx, Inc.: Series D $10M (onbiovc.com) [edit]
  4. Synosia raises $29M for Phase II testing (fiercebiotech.com) [edit]
  5. Capital Report Index [edit]
Edit This Page
Last Edited 10/28/09

Revision History RSS Picture

External Links

Embed Widget

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy